For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Indianapolis, IN, April 3, 2017 — NICO Corporation, a leader in interventional technologies used in a new way of doing brain surgery, announced today the CE Mark for BrainPath – a patented technology that provides non-disruptive access to the brain by uniquely using both a parafascicular and […]
Top Academic Healthcare Centers Presenting New Surgical Options for Stroke Patients
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Houston, February 22, 2017 — New advanced technologies are increasing the effective surgical options to treat hemorrhagic stroke and other cerebrovascular diseases and evidence of improved patient outcomes are the result. The newest standardized surgical approach showing promising results will be featured at the International Stroke Conference […]
FDA Grants New Clearance for Brain Surgery Technology
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Indianapolis, IN, January 31, 2017 — The U.S. Food and Drug Administration (FDA) in less than a 15-month period has granted a new and updated 510(k) clearance for two patented technologies made by NICO Corporation that are used in a new approach for brain surgery. Most recently, […]
Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Indianapolis, February 23, 2016 — NICO Corporation, an Indianapolis-based neurosurgery medical device manufacturer, recently completed a $15 million capital raise important to the expansion of newly developed markets created by their technologies and systems approach to subcortical brain surgery. The funding nearly doubles the total amount raised […]
NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady Memorial
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Randomized controlled trial to help determine best course of treatment for deadliest form of stroke Indianapolis, January 13, 2016 — Two of Atlanta’s nationally renowned comprehensive stroke centers associated with Emory University School of Medicine have joined neurosurgical device maker NICO Corporation to perform a randomized controlled […]
NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain Tumors
For Immediate Release Contact: Meghan Freeman Meghan.freeman@niconeuro.com (317) 627-8856 New Ultrasound Probe Designed to be Compatible with BrainPath™ New Orleans, September 28, 2015 – Neuro surgical device manufacturer NICO Corporation and surgical ultrasound leader Hitachi Aloka Medical America, Inc. have collaborated to provide neurosurgeons real-time, intraoperative imaging to assist with greater extent of resection when […]
NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular Disease
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Decision opens door for new surgical option to once inoperable tumors and blood clots Indianapolis, July 27, 2015 – Brain and spine medical device manufacturer NICO Corporation received additional clearance from the U.S. Food and Drug Administration (FDA) for specific indications on its patented BrainPath technology. The […]
NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions
For Immediate Release Contact: Meghan Freeman Meghan.freeman@niconeuro.com (317) 627-8856 1,600 completed cases show promising clinical and economic results Washington, D.C., May 5, 2015 — Indianapolis based medical device manufacturer NICO Corporation is seeing market adoption of its innovative line of products including the BrainPath® and Myriad™ technologies offering a complete solution for atraumatically accessing deep-seated […]